SCHEMBL10014732

SCHEMBL10014732

CN(C)c1cccc(-c2ccc(F)cc2F)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FYN P06241 7/20 0.43
▸ CNR1 P21554 1/20 0.42
▸ NOTUM Q6P988 2/20 0.41
▸ ALDH1A1 P00352 5/20 0.40
▸ TSHR P16473 1/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ HPGD P15428 2/20 0.40
▸ MAPT P10636 2/20 0.40
▸ KMT2A Q03164 2/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ MEN1 O00255 1/20 0.40
▸ USP2 O75604 1/20 0.40
▸ DHFR P00374 1/20 0.40
▸ CA1 P00915 1/20 0.40
▸ CA2 P00918 1/20 0.40
▸ LMNA P02545 1/20 0.40
▸ TTR P02766 1/20 0.40
▸ ALB P02768 1/20 0.40
▸ HMGB1 P09429 1/20 0.40
▸ CXCL12 P48061 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10304931 0.81 ALDH1A1 (0.48) FYNNOTUMALDH1A1TSHRKDM4E
SCHEMBL14926547 0.79 CNR1 (0.49) CNR1NOTUMALDH1A1KDM4EHPGD
SCHEMBL15495645 0.77 CNR1 (0.48) CNR1ALDH1A1KDM4EHPGDKMT2A
SCHEMBL10014735 0.77 FYN (0.39) FYNNOTUMALDH1A1TSHRKDM4E
SCHEMBL2236879 0.77 AKR1C3 (0.55) CNR1ALDH1A1KDM4EHPGDMAPT
SCHEMBL10014745 0.77 HSD17B14 (0.40) FYNCNR1ALDH1A1KDM4EHPGD
SCHEMBL3835181 0.75 KMT2A (0.55) NOTUMALDH1A1TSHRKDM4EHPGD
SCHEMBL30602821 0.74 ALDH1A1 (0.58) FYNNOTUMALDH1A1TSHRKDM4E
SCHEMBL21420016 0.74 ALDH1A1 (0.48) FYNNOTUMALDH1A1TSHRKDM4E
SCHEMBL30216000 0.73 MEN1 (0.49) CNR1ALDH1A1TSHRKDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120025177-A1 Phosphorescent light-emitting iridium complex containing pyridyltriazole ligand SOLVAY SA (BE) 2012-02-02 — — US disclosed
US-20070221884-A1 Liminescent Silicon Oxide Flakes CIBA SPECIALTY CHEMICALS CORP. 2007-09-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120025177-A1 Phosphorescent light-emitting iridium complex containing pyridyltriazole ligand PPIP5K2, HPRT1, PHPT1 FYN 3882/4885CNR1 3762/4885NOTUM 4610/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback